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Abstract
BACKGROUND—The relationship between body mass index (BMI) and mortality remains 
controversial.
OBJECTIVE—To investigate the relationship between maximum BMI over 16 years and 
subsequent mortality.
DESIGN—Three prospective cohort studies.
SETTING—Nurses’ Health Study I and II, Health Professionals Follow-up Study.
PARTICIPANTS—225,072 men and women accruing 32,571 deaths over a mean of 12.3 years of 
follow-up.
MEASUREMENTS—Maximum BMI over 16 years of weight history and all-cause and cause-
specific mortality.
RESULTS—Maximum BMIs in the overweight (25.0 to 29.9 kg/m2) (multivariate hazard ratio 
(HR), 1.06; 95% confidence interval (CI), 1.03 – 1.08), obese I (30.0 to 34.9 kg/m2), (HR, 1.24; 
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95% CI, 1.20 – 1.29), and obese II (≥ 35.0 kg/m2) (HR, 1.73; 95% CI, 1.66 – 1.80) categories 
were associated with increases in risk of all-cause mortality. The pattern of excess risk with a 
maximum BMI above normal weight was maintained across strata defined by smoking status, sex, 
and age, but the excess was greatest among those <70 years old and never smokers. In contrast, a 
significant inverse association between overweight and mortality (HR, 0.96; 95% CI, 0.94 – 0.99) 
was observed when BMI was defined using a single baseline measurement. Maximum overweight 
was also associated with increased cause-specific mortality, including deaths from cardiovascular 
diseases and coronary heart disease.
LIMITATIONS—Residual confounding and misclassification.
CONCLUSIONS—The paradoxical association between overweight and mortality is reversed in 
analyses incorporating weight history. Maximum BMI may be a useful metric to minimize reverse 
causation bias associated with a single baseline BMI assessment.
INTRODUCTION
There is an ongoing debate about the optimal body mass index (BMI) in relation to all-cause 
mortality. A previous meta-analysis of 97 studies of body mass index and mortality 
identified an inverse association for those who were overweight (25.0 – 29.9 kg/m2) and a 
null association for those with grade 1 obesity (30.0 – 34.9 kg/m2) compared to normal 
weight (18.5 – 24.9 kg/m2) (1). One explanation is that individuals often lose weight due to 
illness before death, leading to reverse causation bias (conditions leading to imminent 
mortality causing lower BMI rather than lower BMI causing mortality) and underestimation 
of the risks of the overweight and obese categories (2, 3). Confounding by smoking may also 
attenuate risks above a normal BMI since smokers tend be leaner (4–6). Techniques such as 
the exclusion of individuals with disease at baseline, exclusion of early follow-up (7) and 
restriction to never-smokers have been proposed (8–10), but these strategies reduce sample 
size, cannot account for participants with diseases of longer latency periods (up to a decade 
or more (11)) or with undiagnosed illnesses, and might reduce generalizability (12, 13).
Several prior studies have investigated mortality risks by using recalled maximum lifetime 
BMI and the results were suggestive of an increased risk with overweight (25.0 – 29.9 
kg/m2) and a significant positive association with obesity (≥ 30.0 kg/m2) (12, 14). This 
method is advantageous because it identifies individuals who maintained a normal BMI over 
time as opposed to entering the normal BMI category due to illness-induced weight loss. 
However, analyses were limited to never-smokers and information on cause-specific 
mortality was not reported. Furthermore, recalled maximum weight has not yet been 
validated against a gold standard.
To address these limitations, we examined all-cause and cause-specific mortality risks of 
overweight and obesity in three large cohorts of health professionals in the United States. 
Our aim was to generate estimates that minimized reverse causality without imposing the 
severe exclusion criteria applied in the prior literature. The availability of longitudinal data 
enabled us to define maximum BMI using contemporaneous rather than recalled data on 
weight status. Furthermore, we included all individuals in the analysis, regardless of 
smoking status, baseline illness and other characteristics.
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The NHS was initiated in 1976 with 121,700 female nurses 30 to 55 years of age. The 
Nurses’ Health Study II (NHS II) began in 1989 with 116,686 younger female registered 
nurses 25 to 42 years of age. The HPFS began in 1986 with 51,529 male health professionals 
40 to 75 years of age. Questionnaires were administered biennially to update diet, lifestyle, 
and other health-related information.
Our primary analysis included women and men who returned at least two questionnaires 
during the weight history periods for each cohort (NHS – 1976 to 1992, NHS II – 1989 to 
2005, HPFS – 1986 to 2002). We excluded individuals if they were missing data on weight 
or age at baseline, died before baseline, or had a BMI less than 12.5 or greater than 60.0 
kg/m2 at baseline. We did not exclude individuals according to baseline illness. The study 
protocol was approved by the institutional review boards of Brigham and Women’s Hospital 
and the Harvard T.H. Chan School of Public Health, with participants’ consent implied by 
the return of the questionnaires.
Assessment of Body Mass Index
Height in inches and body weight in pounds were reported at cohort inception, and body 
weight every 2 years thereafter by self-report. Self-reported weight has been previously 
validated against measured weight in the NHS and HPFS and reported to be highly 
correlated (r = 0.97) (15). BMI was calculated as (703*Weight/Height2). Women who 
reported being pregnant were coded as missing BMI information for that questionnaire 
wave. BMI was categorized into pre-defined categories for analysis: underweight (<18.5 
kg/m2), normal weight (18.5 – 24.9 kg/m2), overweight (25.0 – 29.9 kg/m2), obese I (30.0 – 
34.9 kg/m2), and obese II (≥35.0 kg/m2)(16). Normal weight was used as the reference 
category for both baseline BMI and maximum BMI.
Establishment of Maximum Body Mass Index and Weight History
We define cohort inception in the year that each cohort was founded (NHS – 1976, NHS II – 
1989, HPFS – 1986) and baseline as an arbitrary year after cohort inception at which we 
began to count events and person-time. The weight history period was defined as the period 
between cohort inception and baseline (inclusive of both dates). The main exposure of 
interest, maximum BMI, was defined as the highest reported BMI from any single 
questionnaire returned during the weight history period. For example, the maximum BMI for 
an individual in the NHS using a weight history of 16 years would be equal to the highest 
reported BMI from questionnaires returned in 1976, 1978, 1980, 1982, 1984, 1986, 1988, 
1990, and 1992. The exposure for the same individual using a weight history of 0 years 
would be the BMI reported in 1992 only (equivalent to baseline BMI). The purpose of 
establishing a weight history was to reduce reverse causation owing to individuals losing 
weight due to illness prior to baseline.
To determine the optimal length of weight history, preliminary analyses were first conducted 
with varying lengths of histories (0, 2, 4, 6, 8, 10, 12, 14, and 16 years) from the same 
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baseline year (NHS – 1992, NHS II – 2005, HPFS – 2002), and a period was selected where 
the hazard ratios for the overweight, obese I and obese II categories appeared to stabilize. 
We also considered improvements in model fit according to AIC (Akaike information 
criterion) in our selection (Table S1) (17). For these analyses, we did not stratify by time 
since maximum BMI so that models were comparable. We did not assess model 
performance for weight history lengths exceeding 16 years in the full sample given that this 
would lead to an excessively short follow-up duration in the NHS II. However, weight loss 
typically accelerates 9-10 years before mortality (11), so establishing a weight history length 
of 16 years is expected to capture the maximum BMI of the vast majority of individuals who 
underwent a negative weight trajectory in later life. We began counting events and person-
time after the end of the weight history period until death or the end of follow-up (NHS – 
1992 to 2012, NHS II – 2005 to 2013, HPFS – 2002 to 2012). Individuals who died or were 
lost to follow-up before baseline were not included in the analysis.
Ascertainment of Deaths
The primary outcome was death from any cause through the end of follow-up. Most deaths 
(>98%) were identified from reports by next of kin or postal authorities or from searches of 
the National Death Index. The cause of death was determined by physician review of 
medical records and death certificates. The diagnostic codes of the International 
Classification of Diseases, 8th Revision (ICD-8), were used to classify deaths as due to 
cardiovascular disease (which include heart failure, coronary heart disease, stroke, and any 
other vascular causes) (ICD-8 codes 390 to 459 and 795), coronary heart disease (mainly 
ischemic heart disease) (ICD-8 codes 410 to 414), stroke (ICD-8 codes 430 to 438), cancer 
(ICD-8 codes 140 to 239), respiratory diseases (ICD-8 codes 460 to 519), and other causes 
(such as Alzheimer’s disease, infectious diseases, and accidents).
Assessment of Covariates
Baseline covariates included race (white, non-white), family history of CVD (yes, no), and 
family history of cancer (yes, no). Data on age, cigarette smoking (never, ever, 1–14, 15–24, 
more than 24 cigarettes/day currently), and alcohol intake (0, 0.1–4.9, 5.0–9.9, 10.0–14.9, 
more than 14.9 g/d) were collected and updated from biennial survey data. For the NHS and 
NHS II cohorts only, menopausal status (pre, post, unsure/dubious), hormone therapy use 
(never, ever, current, unsure/dubious) and parity (0, 1, 2, 3, 4 or more) were recorded and 
updated biennially. In the NHS II only, information on oral contraceptive use (never, ever, 
current) was recorded and updated biennially. Dietary information was collected from 
validated food-frequency questionnaires approximately every 4 years for all cohorts and 
updated biennially (18). Covariates with missing values were assigned the last known 
reported value since cohort inception. Otherwise, missing values were set to a separate 
missing data category for that particular covariate and included as an indicator variable in 
the analysis.
Statistical Analysis
Hazard ratios and 95% confidence intervals were estimated from Cox proportional-hazards 
models, with age as the time scale and stratified by questionnaire cycle and years between 
baseline and maximum BMI. Likelihood ratio tests comparing a nested model with each 
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interaction term for maximum BMI category and age category and the full model without 
the interaction terms was not significant for any cohort, signifying that the proportional 
hazards assumption is reasonable for our data. Quintiles for calorie intake were calculated 
from FFQ data. Baseline BMI and maximum BMI throughout weight history were used as 
the primary exposures and were not updated during follow-up in order to emulate extant 
studies and minimize reverse causality. The hazard-ratio estimates for all cohorts were 
combined via fixed effects meta-analysis (19). Sensitivity analyses were conducted 
stratifying by baseline disease exclusions, baseline physical activity, and different inclusion 
criteria for number of surveys returned with BMI data during the weight history period. Data 
were analyzed with the use of SAS software, version 9.4 (SAS Institute), at a two-tailed 
alpha level of 0.05.
RESULTS
Study Participants in Primary Analysis
Baseline characteristics of the three cohorts are presented in Table 1. The follow-up times 
were 1992 to 2012 for the NHS, 2005 to 2013 for the NHS II, and 2002 to 2012 for the 
HPFS (Figure S1). 19.5% of individuals in the NHS, 29.0% of individuals in the NHS II, 
and 20.4% of individuals in the HPFS died before baseline or did not valid weight data at 
baseline and were excluded from the main analysis. A total of 225,072 individuals were 
included in the primary analysis, representing 78.5% of the original study population at 
cohort inception. The mean ages at the start of follow-up were 58, 50, and 68 for the NHS, 
NHS II, and HPFS, respectively. The distributions of maximum BMI for women were wider 
and contained a higher proportion of individuals who were both underweight and obese at 
their heaviest compared to men. Using maximum values, the percentage of individuals 
overweight or obese at baseline was 59% in the NHS, 63% in the NHS 2 and 74% in the 
HPFS. The corresponding values for single baseline BMI were 52%, 57% and 61%. 
Participants in the NHS tended to have higher parity and lower alcohol consumption 
compared to those in the NHS II.
Weight History
The distributions of years from baseline since maximum BMI are depicted in Figures S2 – 
S4. The majority of individuals experienced their maximum BMI during the weight history 
period at the most recent questionnaire (i.e. baseline). Results of the analysis for maximum 
BMI categories according to weight history length are detailed in Table S1. The hazard 
ratios for the maximum overweight and obese categories increased whereas the maximum 
underweight category decreased with longer weight history length. Cohort-specific AIC 
values also decreased with lengthening weight history, signifying better model fit. We 
proceeded with a weight history of 16 years in the primary analysis (1976 to 1992 in the 
NHS, 1989 to 2005 in the NHS II, and 1986 to 2002 in the HPFS) in order to minimize 
reverse causation bias while maximizing follow-up time. The weight history and follow-up 
periods are depicted in Figure S1.
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Among 35,369 males, a total of 7,817 deaths were observed over an accrued 315,205 
person-years of follow-up (mean follow-up time was 8.9 years). We observed significant 
associations of maximum BMI and mortality in the overweight (HR, 1.08; 95% CI, 1.03 – 
1.14), obese I (HR, 1.39; 95% CI, 1.29 – 1.50), and obese II (HR, 1.88; 95% CI, 1.67 – 2.11) 
categories) (Table 2). Compared to those older than age 70, risks of mortality for overweight 
and obesity were higher in adults younger than age 70.
Among 189,703 females, a total of 24,754 deaths accrued over 2.4 million person-years of 
follow-up (mean follow-up time was 12.9 years). We observed a J-shaped relationship for 
maximum BMI and mortality in the underweight (HR, 1.49; 95% CI, 1.26 – 1.76), 
overweight (HR, 1.05; 95% CI, 1.01 – 1.08), obese I (HR, 1.21; 95% CI, 1.16 – 1.26), and 
obese II (HR, 1.71; 95% CI, 1.64 – 1.78) categories (Table 2). HRs for all categories 
strengthened in adults younger than age 60. The hazard ratios for mortality among never-
smokers were generally higher and also followed a J-shaped curve with normal BMI 
conferring the lowest risk (Table 2). Analyses with fine BMI categories revealed that the 
22.5 – 24.9 kg/m2 and 20.0 – 24.9 kg/m2 categories contained the nadir for all-cause 
mortality risk among all individuals and never smokers, respectively (Tables S2 and S8).
Participants who lost a significant amount of weight after attaining their maximum BMI 
showed the highest risk of mortality compared to those who were currently at their 
maximum BMI (Table S6). Those who were < 25.0 kg/m2 at baseline, but were once ≥ 35.0 
kg/m2 during weight history had a HR of 2.60 (95% CI, 2.00 – 3.40). Individuals who were 
<25.0 kg/m2 at baseline but were overweight (25.0–29.9 kg/m2) at their maximum also had 
elevated risks of mortality (HR 1.24; 95% CI, 1.19 – 1.29).
The risks associated with a maximum BMI in the overweight and obese categories remained 
elevated in sensitivity analyses for exclusions for baseline illness (Table S13), exclusions for 
missing BMI data during weight history (Table S14), physical activity levels (Table S15), 
and missing covariate data (Table S16).
Compared to results for maximum BMI in the overweight (HR, 1.06; 95% CI, 1.03, 1.08) 
and obese I (HR, 1.24; 95%, 1.20, 1.29) ranges, the results for baseline BMI were weakened 
for overweight (HR, 0.96; 95% CI, 0.94 – 0.99) and obese I (HR, 1.14; 95% CI, 1.10, 1.18) 
(Figure 1) especially when considering former and current smokers in addition to never 
smokers (Figure 2). Risk of mortality in the underweight BMI group was decreased when 
considering maximum BMI (HR, 1.47; 95% CI, 1.25 – 1.74) instead of baseline BMI only 
(HR, 1.88; 95% CI, 1.75 – 2.01), but still significantly elevated.
Cause-Specific Mortality
We examined the relationship between categories of maximum BMI and mortality due to 
cardiovascular disease (8,017 events), coronary heart disease (3,410 events), stroke (1,998 
events), cancer (11,135 events), respiratory disease (2,607 events), and other causes (10,790 
events) (Table S2). The NHS II was excluded from analyses for respiratory disease, stroke, 
and coronary heart disease due to sparse number of events. The strongest association was 
observed for cardiovascular disease mortality (overweight HR, 1.212 (95% CI, 1.15 – 1.28), 
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obese I HR, 1.63 (95% CI, 1.52 – 1.74), obese II HR, 2.74 (95% CI, 2.53 – 2.97), 
particularly death due to coronary heart disease (overweight HR, 1.32 (95% CI, 1.21 – 1.44), 
obese I HR, 1.97 (95% CI, 1.78 – 2.19), obese II HR, 3.34 (95% CI, 2.95 – 3.79)). The 
association of maximum overweight and mortality from other causes (not CVD, cancer, or 
respiratory diseases) was also significantly elevated (HR, 1.07 (95% CI, 1.02 – 1.12)). 
Compared to the analysis of all individuals, the HRs among never-smokers were generally 
strengthened (Table S8).
DISCUSSION
In our primary analysis of three large cohorts of health professionals using a weight history 
of 16 years, we found that compared to having a maximum BMI of 18.5 – 24.9 kg/m2, those 
with a maximum BMI in the overweight or obese categories were at an elevated incidence of 
mortality from all causes, CVD, and non-CVD/cancer/respiratory causes of death. Our 
findings corroborate previous pooled analyses by the Global BMI Mortality Collaboration 
(7), Prospective Studies Collaboration (20) and Berrington de Gonzalez et al. (6), and a 
recent dose-response meta-analysis (21) suggesting an optimal BMI range of 18.5 to 24.9 
kg/m2 for both never-smokers and all individuals.
Compared to using BMI data from one questionnaire at baseline, use of extended weight 
histories revealed stronger associations with mortality risk, and reversed the paradoxical 
association between overweight and mortality that has been reported in previous analyses 
(1). Although the magnitude of association for a maximum BMI in the overweight category 
was relatively small, this association was robust in sensitivity analyses. The complete 
reversal of the hazard ratio associated with being overweight from significantly protective to 
significantly harmful is also noteworthy, suggesting that reverse causation plays a vital role 
in creating the purported obesity paradox. Furthermore, use of fine BMI categories revealed 
significant increases in risk for individuals who were in the 25.0 to 27.4, as well as the 27.5 
to 29.9 kg/m2 ranges when using the 22.5 – 24.9 kg/m2 category as the reference. These 
significant positive elevations in risk are important from a public health point of view, since 
about a third of adults in the United States and more than a quarter of the world population 
is overweight (22, 23).
Analyses stratified by both maximum BMI and baseline BMI revealed that the highest risks 
of death occurred among those who had experienced substantial decreases in weight, which 
is most likely reflective of unintentional weight loss caused by apparent or preclinical 
disease. Consistent with our findings, weight loss without regard to intent has been identified 
as a significant predictor of mortality (24–27) as the majority of permanent weight loss tends 
to be unintentional (28–30). However, successful intentional weight loss has been associated 
with decreased risk of early mortality (24, 30, 31). By using maximum BMI with an 
extended weight history, we were able to address the problem of reverse causation 
associated with illness-induced weight loss (12, 14). Since weight loss can initiate a decade 
or more prior to death (11), use of an extended weight history is important to minimize bias 
in studies of BMI and mortality. We chose a weight history of 16 years to strike a trade-off 
between minimal reverse causation and maximum follow-up time, but we note that in an 
extended analysis in the NHS only, estimates did not completely stabilize even after 24 years 
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of weight history (Table S17 and S18). Thus, our HRs are likely overestimated for 
underweight and underestimated for overweight and obese maximum BMI.
Our study has several strengths. We analyzed three large cohorts of men and women of 
various ages with long follow-up periods. Enrollment of health professionals allowed for 
high response rates, increased validity of exposure and outcome data, and minimization of 
confounding due to educational and socioeconomic homogeneity. In contrast to using 
retrospective data (12), the prospective nature of our cohorts reduces recall bias and 
selection bias. The establishment of an extended weight history period also diminishes 
reverse causation by capturing BMI data before disease development, even if the disease had 
not been diagnosed, allowing us to retain the vast majority of individuals in our study (11). 
Our analyses that included only never-smokers showed a similar J-shaped association with 
greater magnitude of excess risk in all BMI categories exceeding the normal weight 
category, enhancing the generalizability of our results.
Limitations include the use of data originating from predominately white participants mostly 
of high socioeconomic status. Future research may benefit from incorporation of maximum 
BMI with weight history to study mortality in other diverse cohorts. We also cannot rule out 
residual confounding and confounding by unmeasured variables. Although the use of BMI 
as a measure for adiposity is imperfect, as it does not differentiate between fat and lean body 
mass, the majority of population variance in adiposity is explained by BMI (2, 32). Since 
BMI was self-reported, there may be systematic underestimation of true BMI, although the 
correlation between self-reported and measured weight was generally high in the NHS (r2 = 
0.97) (15). Recalled maximum BMI should also be validated against longitudinal data, since 
such a measure would capture lifetime maximum BMI. A prior study investigating the 
validity of recalled maximum BMI found a strong correlation with contemporaneous data, 
however, in this study the gold standard was based on self-reported data and validity was 
only evaluated over a twelve-year period (33). Finally, there were a substantial number of 
individuals who had missing BMI values from at least one survey cycle, which may 
introduce bias if survey cycles with missing weight data were more likely to have been that 
individual’s maximum weight.
Our findings suggest that minimum risk of mortality occurs among those with a maximum 
BMI in the range of 18.5 – 24.9 kg/m2 at all ages, regardless of sex and smoking status. 
Maximum BMIs in the overweight and obese categories were associated with elevated risks 
of all-cause mortality and deaths due to CVD, cancer, and other causes. In contrast to 
baseline BMI, use of maximum BMI with an extended weight history period appears to 
minimize reverse causation due to illness-induced weight loss.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Graph comparing hazard ratios for maximum BMI with 16 years of weight history and 
baseline BMI among all individuals.
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Graph comparing hazard ratios for maximum BMI with 16 years of weight history and 
baseline BMI among never-smokers.
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TABLE 1







Age (y) 58.4 ± 7.2 50.4 ± 4.6 68.3 ± 8.9
Smoking status (%)
Never 43.7 64.9 46.5
Ever 40.9 27.0 45.8
Current 14.4 7.9 3.1
Maximum BMI (%)
Under (<18.5 kg/m2) 0.4 0.3 0.1
Normal (18.5–24.9 kg/m2) 40.8 36.1 27.4
Over (25.0–29.9 kg/m2) 35.0 30.5 53.5
Obese I (30.0–34.9 kg/m2) 15.3 16.9 15.2
Obese II (>34.9 kg/m2) 8.5 16.0 3.8
Baseline BMI (%)
Under (<18.5 kg/m2) 1.4 1.1 0.5
Normal (18.5–24.9 kg/m2) 46.7 42.3 38.6
Over (25.0–29.9 kg/m2) 32.5 29.0 47.1
Obese I (30.0–34.9 kg/m2) 13.1 15.3 11.2
Obese II (>34.9 kg/m2) 6.3 12.3 2.5
White (%) 93.7 96.1 91.4
Family history CVD (%) 15.8 21.8 33.1








































Alcohol at baseline (%)
Never (0 g/d) 45.5 42.0 15.3
Very Light (0.1 – 4.9 g/d) 29.8 33.8 28.2
Light (5.0 – 9.9 g/d) 9.6 11.5 17.2
Moderate (10.0 – 14.9 g/d) 6.4 6.6 13.0
Heavy (>14.9 g/d) 8.8 6.2 26.4
Total energy intake at baseline (kcal/d) 1758 ± 491 1832 ± 534 1986 ± 538
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